These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

248 related articles for article (PubMed ID: 29188502)

  • 1. Small Scale Production of Recombinant Adeno-Associated Viral Vectors for Gene Delivery to the Nervous System.
    Verhaagen J; Hobo B; Ehlert EME; Eggers R; Korecka JA; Hoyng SA; Attwell CL; Harvey AR; Mason MRJ
    Methods Mol Biol; 2018; 1715():3-17. PubMed ID: 29188502
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Small and Micro-Scale Recombinant Adeno-Associated Virus Production and Purification for Ocular Gene Therapy Applications.
    Reid CA; Lipinski DM
    Methods Mol Biol; 2018; 1715():19-31. PubMed ID: 29188503
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preparation and Administration of Adeno-associated Virus Vectors for Corneal Gene Delivery.
    Song L; Bower JJ; Hirsch ML
    Methods Mol Biol; 2020; 2145():77-102. PubMed ID: 32542602
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adeno-associated virus vector-mediated gene transfer to somatic cells in the central nervous system.
    Klein RL; Mandel RJ; Muzyczka N
    Adv Virus Res; 2000; 55():507-28. PubMed ID: 11050954
    [No Abstract]   [Full Text] [Related]  

  • 5. Production of clinical-grade recombinant adeno-associated virus vectors.
    Snyder RO; Flotte TR
    Curr Opin Biotechnol; 2002 Oct; 13(5):418-23. PubMed ID: 12459331
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Small-Scale Recombinant Adeno-Associated Virus Purification.
    Burger C; Nash KR
    Methods Mol Biol; 2016; 1382():95-106. PubMed ID: 26611581
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Production of recombinant adeno-associated viral vectors and use in in vitro and in vivo administration.
    Gray SJ; Choi VW; Asokan A; Haberman RA; McCown TJ; Samulski RJ
    Curr Protoc Neurosci; 2011 Oct; Chapter 4():Unit 4.17. PubMed ID: 21971848
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adeno-associated viral vectors for gene therapy of inherited retinal degenerations.
    Flannery JG; Visel M
    Methods Mol Biol; 2013; 935():351-69. PubMed ID: 23150381
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Scalable Production and Purification of Adeno-Associated Viral Vectors (AAV).
    Blessing D; Déglon N; Schneider BL
    Methods Mol Biol; 2018; 1850():259-274. PubMed ID: 30242692
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Purification of recombinant adeno-associated virus by iodixanol gradient ultracentrifugation allows rapid and reproducible preparation of vector stocks for gene transfer in the nervous system.
    Hermens WT; ter Brake O; Dijkhuizen PA; Sonnemans MA; Grimm D; Kleinschmidt JA; Verhaagen J
    Hum Gene Ther; 1999 Jul; 10(11):1885-91. PubMed ID: 10446928
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Optimized Subretinal Injection Technique for Gene Therapy Approaches.
    Mühlfriedel R; Michalakis S; Garrido MG; Sothilingam V; Schön C; Biel M; Seeliger MW
    Methods Mol Biol; 2019; 1834():405-412. PubMed ID: 30324458
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adeno-associated virus vectors: versatile tools for in vivo gene transfer.
    Zentilin L; Giacca M
    Contrib Nephrol; 2008; 159():63-77. PubMed ID: 18391585
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recombinant adeno-associated viral vectors.
    de Backer MW; Garner KM; Luijendijk MC; Adan RA
    Methods Mol Biol; 2011; 789():357-76. PubMed ID: 21922421
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adeno-associated virus (AAV) based gene therapy for eye diseases.
    Wang S; Liu P; Song L; Lu L; Zhang W; Wu Y
    Cell Tissue Bank; 2011 May; 12(2):105-10. PubMed ID: 21344187
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Developments in gene delivery vectors for ocular gene therapy].
    Khabou H; Dalkara D
    Med Sci (Paris); 2015 May; 31(5):529-37. PubMed ID: 26059304
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Production of recombinant adeno-associated viral vectors for in vitro and in vivo use.
    Choi VW; Asokan A; Haberman RA; Samulski RJ
    Curr Protoc Mol Biol; 2007 Apr; Chapter 16():Unit 16.25. PubMed ID: 18265393
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Production and purification of recombinant adeno-associated vectors.
    Wang L; Blouin V; Brument N; Bello-Roufai M; Francois A
    Methods Mol Biol; 2011; 807():361-404. PubMed ID: 22034039
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Protocol for Efficient Generation and Characterization of Adeno-Associated Viral Vectors.
    Jungmann A; Leuchs B; Rommelaere J; Katus HA; Müller OJ
    Hum Gene Ther Methods; 2017 Oct; 28(5):235-246. PubMed ID: 29048971
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Production and Characterization of Vectors Based on the Cardiotropic AAV Serotype 9.
    Kohlbrenner E; Weber T
    Methods Mol Biol; 2017; 1521():91-107. PubMed ID: 27910043
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development and optimization of adeno-associated virus vector transfer into the central nervous system.
    During MJ; Young D; Baer K; Lawlor P; Klugmann M
    Methods Mol Med; 2003; 76():221-36. PubMed ID: 12526166
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 13.